The effect of ablation of eosinophils on immediate-type hypersensitivity reactions.

di Gleich, G J, Olson, G M, Loegering, D A
Pubblicazione 1979

Purification of human eosinophil-derived neurotoxin.

di Durack, D T, Ackerman, S J, Loegering, D A, Gleich, G J
Pubblicazione 1981

Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils.

di Gleich, G J, Loegering, D A, Mann, K G, Maldonado, J E
Pubblicazione 1976

Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm

di Lee, S-H, Meng, X W, Flatten, K S, Loegering, D A, Kaufmann, S H
Pubblicazione 2013

Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease.

di Gleich, G J, Loegering, D A, Bell, M P, Checkel, J L, Ackerman, S J, McKean, D J
Pubblicazione 1986

Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia.

di Wassom, D L, Loegering, D A, Solley, G O, Moore, S B, Schooley, R T, Fauci, A S, Gleich, G J
Pubblicazione 1981

Acidic polyamino acids inhibit human eosinophil granule major basic protein toxicity. Evidence of a functional role for ProMBP.

di Barker, R L, Gundel, R H, Gleich, G J, Checkel, J L, Loegering, D A, Pease, L R, Hamann, K J
Pubblicazione 1991